Simultaneous laparoscopic proctocolectomy (TaTME) and robot-assisted radical prostatectomy for synchronous rectal and prostate cancer

Gys, Ben; Fransis, Karen; Hubens, Guy; Broeck, Sylvie Van den; Beeck, Bart Op de; Komen, Niels

doi:10.1080/00015458.2017.1411550

Cited by 4 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, this technique may have further merit as synchronous surgery, such as type 2 or 3 surgery. We performed robot‐assisted laparoscopic rectal cancer surgery and RARP simultaneously in two cases, and simultaneous surgery for synchronous rectal and prostate cancer were previously reported in three other cases: Park et al performed robot‐assisted laparoscopic rectal cancer surgery and RARP, 17 Kamiyama et al performed laparoscopic rectal cancer surgery and RARP, 18 and Gys et al reported simultaneous laparoscopic transanal TME (TaTME) and RARP for synchronous rectal and prostate cancer 19 . Each procedure, including our technique, has its own merits and demerits.…”

Section: Discussionmentioning

confidence: 81%

“…We performed robot-assisted laparoscopic rectal cancer surgery and RARP simultaneously in two cases, and simultaneous surgery for synchronous rectal and prostate cancer were previously reported in three other cases: Park et al performed robot-assisted laparoscopic rectal cancer surgery and RARP, 17 Kamiyama et al performed laparoscopic rectal cancer surgery and RARP, 18 and Gys et al reported simultaneous laparoscopic transanal TME (TaTME) and RARP for synchronous rectal and prostate cancer. 19 Each procedure, including our technique, has its own merits and demerits. If we could perform robotic rectal cancer surgery with RS-RARP, it would likely reduce the operation time and the blood loss dramatically, and future studies will explore this possibility.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The clinical impact of robot‐assisted laparoscopic rectal cancer surgery associated with robot‐assisted radical prostatectomy

Maeda

Takahashi

Watanabe

et al. 2021

Asian J Endoscop Surgery

View full text Add to dashboard Cite

Introduction: Robot-assisted laparoscopic surgery has been performed in various fields, especially in the pelvic cavity. However, little is known about the utility of robot-assisted laparoscopic rectal cancer surgery associated with robot-assisted radical prostatectomy (RARP). We herein report the clinical impact of robot-assisted laparoscopic rectal cancer surgery associated with RARP.Methods: We experienced five cases of robot-assisted laparoscopic rectal cancer surgery associated with RARP. One involved robot-assisted laparoscopic abdominoperineal resection with en bloc prostatectomy for T4b rectal cancer, and one involved robot-assisted laparoscopic intersphincteric resection combined with RARP for synchronous rectal and prostate cancer. The remaining three involved robot-assisted laparoscopic low anterior resection (RaLAR) after RARP. For robot-assisted laparoscopic rectal cancer surgery, the da Vinci Xi surgical system was used. Results: We could perform planned robotic rectal cancer surgery in all cases.The median operation time was 529 min (373-793 min), and the median blood loss was 307 ml (32-1191 ml). No patients required any transfusion in the intra-operative or immediate peri-operative period. The circumferential resection margin was negative in all cases. There were no complications of grade ≥III according to the Clavien-Dindo classification and no conversions to conventional laparoscopic or open surgery. Conclusion:Robot-assisted laparoscopic surgery associated with RARP is feasible in patients with rectal cancer. The long-term surgical outcomes remain to be further evaluated.

show abstract

Section: Discussionmentioning

confidence: 81%

Section: Discussionmentioning

confidence: 99%

The clinical impact of robot‐assisted laparoscopic rectal cancer surgery associated with robot‐assisted radical prostatectomy

Maeda

Takahashi

Watanabe

et al. 2021

Asian J Endoscop Surgery

View full text Add to dashboard Cite

show abstract

“…Further assessment of eligibility, based on the study of the full-text papers, led to the exclusion of 83 papers. Finally, 27 studies involving 252 patients were included in the final analysis ( Figure 1 ) [ 1 , 2 , 7 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ]. Of these, 19 studies involved only patients with synchronous cancers, 5 studies involved only metachronous PCa patients, and 3 studies involved mixed populations.…”

Section: Resultsmentioning

confidence: 99%

Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published Evidence

et al. 2022

View full text Add to dashboard Cite

The management of patients with prostate cancer (PCa) and previous or synchronous colorectal cancer (CRC) represents a challenging issue. A systematic review was performed in May 2022 to summarize available evidence about the diagnosis, management, and outcomes of these patients. Twenty-seven studies involving 252 patients were identified. Overall, 163 (64.7%) and 89 (35.3%) patients had synchronous and metachronous PCa and CRC, respectively. In patients with synchronous diseases, PCa treatment involved active surveillance in 1 patient, radical prostatectomy (RP) in 36 patients, radiotherapy (RT) in 60 patients, RP plus RT in 1 patient, proton beam therapy in 1 patient, and cryoablation in 1 patient. In patients with previous CRC treatment, prostate biopsy was mostly performed by transrectal approach (n = 24). The trans-perineal and suprapubic approaches were adopted in 12 and 6 cases, respectively. Surgical PCa treatment in these cases involved endoscopic extraperitoneal RP, robot-assisted RP, and not otherwise specified RP in 30, 15, and 2 cases, respectively. Biochemical recurrence rates ranged from 20% to 28%. Non-surgical PCa treatment options included brachytherapy, RT plus androgen deprivation therapy, and RT alone in 23, 2 and 4 patients, respectively. PCa specific survival was reported by one study and was 100%.

show abstract

“…Lastly, a peculiar situation in which RS-RARP offers advantages is the case in which the patient needs a rectal resection and a radical prostatectomy at the same time (advanced rectal cancer, prostatic sarcomas, concomitant prostate and rectal cancer, and so on). Having a posterior access allows to manage the surgery safely, from the same approach, protecting the bladder [54][55][56][57].…”

Section: Special Situations and Atypical Advantagesmentioning

confidence: 99%

The spread of retzius-sparing robotic prostatectomy: an update after 10 years

Galfano

Secco

Olivero

et al. 2023

Current Opinion in Urology

View full text Add to dashboard Cite

Purpose of reviewObjective of our work is to provide an update of the state of the art concerning Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) and to give a possible vision on the future developments of this new approach.Recent findingsA nonsystematic literature review has been conducted, finding 27 comparative studies and 24 reviews published up to April 15, 2023. Most of these studies confirm the advantages of RS-RARP relative to standard RARP mainly on early continence recovery. Conversely, discordant findings are reported for the benefit of RS-RARP on late continence recovery. Uncertainty is still present on the impact on positive surgical margins (PSMs), but this statement is based on low level of evidence. Several data concerning the learning curve have shown the safety of RS-RARP, but the need of adequate tutoring. Recent studies also confirmed the feasibility of RS-RARP in the setting of high-risk prostate cancer (PCa), large prostate volume, patients with an history of benign prostatic hyperplasia surgery and patients with a transplanted kidney. Atypical advantages can be also seen in the reduction of risk of postoperative inguinal hernias and in case of concomitant rectal resection.SummaryRetzius-sparing RARP has been confirmed to be one of the standard approaches for the treatment of PCa, with well documented advantages and uncertainty on PSMs.

show abstract

Simultaneous laparoscopic proctocolectomy (TaTME) and robot-assisted radical prostatectomy for synchronous rectal and prostate cancer

Abstract: In this case, the combination of TaTME and Retzius sparing RARP for synchronous rectal and prostate cancer was feasible and safe. We suggest performing the anterior TaTME dissection last, due to disturbing blood flow into the operating field after prostatectomy.

Cited by 4 publications

References 17 publications

The clinical impact of robot‐assisted laparoscopic rectal cancer surgery associated with robot‐assisted radical prostatectomy

The clinical impact of robot‐assisted laparoscopic rectal cancer surgery associated with robot‐assisted radical prostatectomy

Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published Evidence

The spread of retzius-sparing robotic prostatectomy: an update after 10 years

Contact Info

Product

Resources

About